Hepatitis C virus (HCV) is a bloodborne pathogen whose infection course is characterized by a distinct clinical staging (prodromal, pre-icteric, icteric phases) and a high rate of progression from acute to chronic infection, with chronic viremia carrying risk of cirrhosis and liver failure; unlike some other viral hepatitides, antibody formation does not confer immunity due to high envelope-protein variability. Diagnosis relies on a two-tiered serologic and molecular testing framework distinguishing prior exposure from active infection, while treatment is grounded in the principle of direct-acting antivirals targeting discrete steps of the viral proliferation cycle, within the domain of virology/infectious disease and clinical hepatology.
Hepatitis C virus (HCV) is a bloodborne pathogen whose infection course is characterized by a distinct clinical staging (prodromal, pre-icteric, icteric phases) and a high rate of progression from ac…